Electrical Vestibular Stimulation for Dizziness
(VST Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Electrical Vestibular Stimulation (EVS) for dizziness?
Research on a similar treatment, electrotactile vestibular substitution system (EVSS), showed that patients with vestibular loss experienced improved balance and reduced dizziness after using the system. Additionally, studies on electric stimulation in animals indicated faster recovery from balance issues, suggesting potential benefits for dizziness treatment.12345
Is electrical vestibular stimulation safe for humans?
How is the treatment Electrical Vestibular Stimulation (EVS) unique for treating dizziness?
Electrical Vestibular Stimulation (EVS) is unique because it uses electrical currents to directly stimulate the vestibular system, which is responsible for balance and spatial orientation. Unlike traditional treatments like medication or surgery, EVS aims to artificially restore vestibular function and has shown promise in improving balance and reducing dizziness by enhancing vestibular compensation.211121314
What is the purpose of this trial?
The aim of the study to is determine the safety, feasibility, efficacy, and persistence of non-invasive EVS to improve balance and gait performance in healthy individuals across the lifespan. Specifically, our objective is to measure balance and gait performance before, during and after exposure to single sessions and across repeated sequences of EVS at multiple study partner sites.
Research Team
Ryan M Peters, PhD
Principal Investigator
University of Calgary
Eligibility Criteria
This trial is for healthy individuals who experience dizziness and are interested in testing a non-invasive treatment to improve balance and gait. Specific eligibility criteria details were not provided, so general health status may be considered.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 18 sessions of electrical vestibular stimulation (EVS) over a 5-6 week period to improve balance and gait performance.
Follow-up
Participants are monitored for persistence of performance improvements with follow-up sessions at 3 weeks, 6 weeks, 3 months, and 6 months post-treatment.
Treatment Details
Interventions
- Electrical Vestibular Stimulation (EVS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Neursantys Inc
Lead Sponsor
Mitacs
Industry Sponsor
University of Calgary
Collaborator